Company Evolutionary Genomics, Inc.

Equities

FNAM

US30051F1012

Biotechnology & Medical Research

Market Closed - OTC Markets 20:26:12 18/07/2023 BST 5-day change 1st Jan Change
0.45 USD -25.00% Intraday chart for Evolutionary Genomics, Inc. -.--% -.--%

Business Summary

Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.

Number of employees: 3

Managers

Managers TitleAgeSince
Founder 69 31/10/90
Chief Executive Officer 68 31/08/10

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 68 31/08/10
Director/Board Member 64 31/12/09
Founder 74 31/10/90

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 189,337 0 0 67.35 %
Stock B 1 6,655,232 4,482,324 ( 67.35 %) 0
Stock C 0 577,063 0 0

Shareholders

NameEquities%Valuation
1,841,374 27.67 % 1 M $
182,044 2.735 % 119 239 $
123,490 1.856 % 80 886 $
26,000 0.3907 % 17 030 $

Company contact information

Evolutionary Genomics, Inc.

4220 Morning Star Drive

80108, Castle Rock

+

http://www.evolgen.com
address Evolutionary Genomics, Inc.(FNAM)
  1. Stock Market
  2. Equities
  3. FNAM Stock
  4. Company Evolutionary Genomics, Inc.